Robin Carson
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
-
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
- CAR-T cell therapy research
Papers in
- Hematology 32
- Multiple Myeloma Research and Treatments 29
- Chronic Myeloid Leukemia Treatments 4
- Oncology 18
- Peptidase Inhibition and Analysis 8
- Cancer Treatment and Pharmacology 7
- Co-authors
- Pieter Sonneveld (9 shared papers)María‐Victoria Mateos (8 shared papers)Andrew Spencer (8 shared papers)Tahamtan Ahmadi (5 shared papers)Meletios Α. Dimopoulos (10 shared papers)Meral Beksaç (6 shared papers)Katja Weisel (4 shared papers)Jesús F. San Miguel (6 shared papers)
- Journals
- Journal of Clinical Oncology (10 papers)Blood (7 papers)Annals of Hematology (3 papers)HemaSphere (2 papers)Blood Cancer Journal (1 paper)
- Partner nations
- United StatesSpainNetherlands
In The Last Decade
Robin Carson
29 papers receiving 252 citations
Peers
Comparison fields: 5 of 41
- Hematology 204
- Oncology 160
- Genetics 36
- Molecular Biology 138
- Radiology, Nuclear Medicine and Imaging 28
Countries citing papers authored by Robin Carson
This map shows the geographic impact of Robin Carson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Carson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Carson more than expected).
Fields of papers citing papers by Robin Carson
This network shows the impact of papers produced by Robin Carson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Carson. The network helps show where Robin Carson may publish in the future.
Co-authors
The 25 scholars most cited alongside Robin Carson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 63 | |
| 2 | 2019 | 31 | |
| 3 | 2022 | 19 | |
| 4 | 2021 | 15 | |
| 5 | 2020 | 12 | |
| 6 | 2020 | 12 | |
| 7 | 2021 | 10 | |
| 8 | 2022 | 10 | |
| 9 | 2022 | 10 | |
| 10 | 2024 | 9 | |
| 11 | 2015 | 9 | |
| 12 | 2019 | 7 | |
| 13 | 2023 | 6 | |
| 14 | 2020 | 6 | |
| 15 | 2022 | 6 | |
| 16 | 2023 | 5 | |
| 17 | 2022 | 4 | |
| 18 | 2022 | 4 | |
| 19 | 2023 | 4 | |
| 20 | 2022 | 3 |
About Robin Carson
Robin Carson is a scholar working on Hematology, Oncology, Molecular Biology, Genetics and Infectious Diseases, having authored 33 papers that have together received 258 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (29 papers), Protein Degradation and Inhibitors (8 papers), Chronic Lymphocytic Leukemia Research (8 papers), Peptidase Inhibition and Analysis (8 papers), Cancer Treatment and Pharmacology (7 papers), HIV/AIDS drug development and treatment (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Chronic Myeloid Leukemia Treatments (4 papers). The work is most often cited by research in Hematology (204 citations), Oncology (160 citations), Genetics (36 citations), Molecular Biology (138 citations) and Radiology, Nuclear Medicine and Imaging (28 citations). Robin Carson has collaborated with scholars based in United States, Spain and Netherlands. Frequent co-authors include Pieter Sonneveld, María‐Victoria Mateos, Andrew Spencer, Tahamtan Ahmadi, Meletios Α. Dimopoulos, Meral Beksaç, Katja Weisel, Jesús F. San Miguel, Wendy Crist and Mark‐David Levin. Their work appears in journals such as Journal of Clinical Oncology, Blood, Annals of Hematology, HemaSphere and Blood Cancer Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.